Pharmaceutical Care for a High Paraplegia Patient with Hospital Acquired Pneumonia / 中国药房
China Pharmacy
; (12): 3729-3730,3731, 2015.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-605369
Biblioteca responsável:
WPRO
ABSTRACT
OBJECTIVE:
To investigate the role of clinical pharmacists in the treatment of high paraplegia patient with hospital acquired pneumonia.METHODS:
Clinical pharmacists provided suggestions for anti-infective treatment failure of a high paraplegia patient with hospital acquired pneumonia,including anti-infective treatment of imipenem and cilastatin sodi-um 1.0 g,ivgtt,qid,de-escalation anti-infective treatment of cefoperazone sodium and sulbactam sodium 3.0 g,ivgtt,bid+amikacin 0.4 g,ivgtt,bid,and prevention treatment of fluconazole sodium chloride 0.2 g,ivgtt,qd against potential invasive infections with fungi,etc.,assisted physician to improve therapy plan,monitor ADR and guide rational drug use. RE-SULTSAfter 3 weeks of treatment,the symptoms had been improved significantly.CONCLUSIONS:
Clinical pharmacists provide individual pharmaceutical care to reduce ADR during treatment and improve the effectiveness and safety of clinical treatment.
Texto completo:
Disponível
Contexto em Saúde:
ODS3 - Meta 3.3 Acabar com as doenças tropicais negligenciadas e combater as doenças transmissíveis
Problema de saúde:
Pneumonía
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
China Pharmacy
Ano de publicação:
2015
Tipo de documento:
Artigo